Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk E Hevener

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2018
Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit ValidationKirk E Hevener
Biochemical and Biophysical Research Communications|June 18, 2019
Crystal structure of the 65-kilodalton amino-terminal fragment of DNA topoisomerase I from the gram-positive model organism Streptococcus mutansJesse A Jones, Kirk E Hevener
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2024
Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit ValidationKyle R Kauler, Kirk E Hevener
American Journal of Pharmaceutical Education|July 20, 2024
Professional Pharmacy Fraternities as a Mechanism for Cocurricular Learning: A Qualitative Analysis of Two OrganizationsCaitlin M Gibson, Matthew Lacroix, Kirk E Hevener
Antimicrobial Agents and Chemotherapy|November 13, 2019
Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 InflammasomeDavid J Lowes, Kirk E Hevener, Brian M Peters
Biochemical and Biophysical Research Communications|March 8, 2024
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitorsFahad Bin Aziz Pavel, Glen E Palmer, Kirk E Hevener
Protein Expression and Purification|April 28, 2016
A simplified protocol for high-yield expression and purification of bacterial topoisomerase IJesse A Jones, Emily Price, Donovan Miller, et al.
Medchemcomm|September 20, 2016
Recent Advances in the Rational Design and Optimization of Antibacterial AgentsJesse A Jones, Kristopher G Virga, Giuseppe Gumina, et al.
Bioorganic & Medicinal Chemistry|August 15, 2008
Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agentsKirk E Hevener, David M Ball, John K Buolamwini, et al.
BMC Bioinformatics|July 22, 2009
A statistical framework to evaluate virtual screeningWei Zhao, Kirk E Hevener, Stephen W White, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|June 24, 2018
Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit ValidationKirk E Hevener
Biochemical and Biophysical Research Communications|June 18, 2019
Crystal structure of the 65-kilodalton amino-terminal fragment of DNA topoisomerase I from the gram-positive model organism Streptococcus mutansJesse A Jones, Kirk E Hevener
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2024
Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit ValidationKyle R Kauler, Kirk E Hevener
American Journal of Pharmaceutical Education|July 20, 2024
Professional Pharmacy Fraternities as a Mechanism for Cocurricular Learning: A Qualitative Analysis of Two OrganizationsCaitlin M Gibson, Matthew Lacroix, Kirk E Hevener
Antimicrobial Agents and Chemotherapy|November 13, 2019
Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 InflammasomeDavid J Lowes, Kirk E Hevener, Brian M Peters
Biochemical and Biophysical Research Communications|March 8, 2024
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitorsFahad Bin Aziz Pavel, Glen E Palmer, Kirk E Hevener
Protein Expression and Purification|April 28, 2016
A simplified protocol for high-yield expression and purification of bacterial topoisomerase IJesse A Jones, Emily Price, Donovan Miller, et al.
Medchemcomm|September 20, 2016
Recent Advances in the Rational Design and Optimization of Antibacterial AgentsJesse A Jones, Kristopher G Virga, Giuseppe Gumina, et al.
Bioorganic & Medicinal Chemistry|August 15, 2008
Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agentsKirk E Hevener, David M Ball, John K Buolamwini, et al.
BMC Bioinformatics|July 22, 2009
A statistical framework to evaluate virtual screeningWei Zhao, Kirk E Hevener, Stephen W White, et al.
Pageof 5